Literature DB >> 9832092

Esophageal dysfunction in syndrome X.

M Börjesson1, P Albertsson, M Dellborg, T Eliasson, M Pilhall, P Rolny, C Mannheimer.   

Abstract

Syndrome X is defined as anginal chest pain accompanied by objective signs of ischemia on exercise testing or myocardial scintigraphy, but with angiographically "normal" coronary arteries. The etiology of this enticing syndrome is still not known. Besides myocardial ischemia, esophageal dysfunction and visceral hypersensitivity may play a role in the development of pain. The purpose of this study was to study esophageal function and visceral sensitivity in patients with syndrome X. Twenty consecutive patients with the diagnosis of syndrome X were investigated with esophageal manometry and a 24-hour pH recording. Visceral esophageal sensitivity was explored by balloon distention of the distal esophagus, as well as by instillation of acid. Twelve patients (67% of the 18 evaluated) had some abnormality on 24-hour pH monitoring; 2 had abnormal global acid exposure time (pH <4) and 7 had symptoms coincidental with episodes of pH <4. Seven patients (35%) had esophageal dysmotility including 5 with the "nutcracker" esophagus. Esophageal hypersensitivity to acid (n = 9) or distention (n = 13) was seen in 14 of the 20 patients. Eleven patients received acid suppressive therapy that resulted in amelioration of chest pain in 8 (73%). Thus, results suggest that esophageal hypersensitivity rather than gross functional abnormality is an important factor for the development of chest pain in patients with syndrome X, and that acid in the context of a hypersensitive esophagus is the main culprit. Acid suppression may ameliorate pain in a substantial proportion of patients.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9832092     DOI: 10.1016/s0002-9149(98)00598-0

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  5 in total

Review 1.  Role of the vascular endothelium in patients with angina pectoris or acute myocardial infarction with normal coronary arteries.

Authors:  J Sztajzel; F Mach; A Righetti
Journal:  Postgrad Med J       Date:  2000-01       Impact factor: 2.401

Review 2.  Recent developments in chest pain of undetermined origin.

Authors:  S R Achem; K R DeVault
Journal:  Curr Gastroenterol Rep       Date:  2000-06

Review 3.  Visceral chest pain in unstable angina pectoris and effects of transcutaneous electrical nerve stimulation. (TENS). A review.

Authors:  M Börjesson
Journal:  Herz       Date:  1999-04       Impact factor: 1.443

Review 4.  Recent developments in microvascular angina.

Authors:  O Ali; F W Smart; T Nguyen; H Ventura
Journal:  Curr Atheroscler Rep       Date:  2001-03       Impact factor: 5.113

5.  EMERGING THERAPIES AND NOVEL APPROACHES TO VISCERAL PAIN.

Authors:  Ursula Wesselmann; Andrew P Baranowski; Mats Börjesson; Natasha C Curran; Peter P Czakanski; Maria Adele Giamberardino; Timothy J Ness; Meredith T Robbins; Richard J Traub
Journal:  Drug Discov Today Ther Strateg       Date:  2009
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.